“Mitochondriology”: New approaches in bioenergetics (III-S14)

Chairs: Sergio Papa
  Vladimir Skulachev

July 8, 2013 Mitochondrial Pathologies

08.30 - 09.10

Flint Beal   Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, USA

Mitochondrial dysfunction in human diseases

09.10 - 09.35

Agnès Rötig   DR1 INSERM, INSERM U781, Hôpital Necker-Enfants Malades, Paris, France

Translation deficiencies in mitochondrial disorders

09.35 -10.00

Domenico De Rasmo   Institute of Biomembranes and Bioenergetics (IBBE), Consiglio Nazionale delle Ricerche, Bari, Italy

Signal transduction and complex I regulation: pathophysiological implications

10.00 -10.25

Maxim V. Skulachev   Belozersky Institute of Physico–Chemical Biology and Institute of Mitoengineering, Moscow State University, Moscow, Russia

SkQ, the first mitochondria-targeted medicine tested in humans: clinical trials and therapy of the dry eye syndrome, an incurable age-related disease